127 related articles for article (PubMed ID: 37782202)
1. Cytokine release syndrome in Crimean-Congo hemorrhagic fever: can IL-1 receptor antagonist levels be a guide in its treatment?
Çelik N; Laloğlu E
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8934-8942. PubMed ID: 37782202
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of seroprevalence and clinical and laboratory findings of patients admitted to health institutions in Gümüşhane with suspicion of Crimean-Congo hemorrhagic fever.
Gürbüz E; Ekici A; Ünlü AH; Yılmaz H
Turk J Med Sci; 2021 Aug; 51(4):1825-1832. PubMed ID: 33754650
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the associations between endothelial dysfunction, inflammation and coagulation in Crimean-Congo hemorrhagic fever patients.
Doğan HO; Büyüktuna SA; Kapancik S; Bakir S
Arch Virol; 2018 Mar; 163(3):609-616. PubMed ID: 29159591
[TBL] [Abstract][Full Text] [Related]
4. IL-36 signaling pathway dysregulation in Crimean-Congo hemorrhagic fever virus patients: A potential therapeutic avenue.
Doğan K; Büyüktuna SA
J Med Virol; 2024 Jan; 96(1):e29347. PubMed ID: 38152020
[TBL] [Abstract][Full Text] [Related]
5. Crucial parameter of the outcome in Crimean Congo hemorrhagic fever: Viral load.
Hasanoglu I; Guner R; Carhan A; Kocak Tufan Z; Yagci-Caglayik D; Guven T; Yilmaz GR; Tasyaran MA
J Clin Virol; 2016 Feb; 75():42-6. PubMed ID: 26780111
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions.
Ozturk B; Tutuncu E; Kuscu F; Gurbuz Y; Sencan I; Tuzun H
Int J Infect Dis; 2012 Feb; 16(2):e89-93. PubMed ID: 22154082
[TBL] [Abstract][Full Text] [Related]
7. [Bleeding Risk Score in Patients with Crimean-Congo Hemorrhagic Fever].
Karaşahin Ö; Karaşahin EF
Mikrobiyol Bul; 2021 Jul; 55(3):327-341. PubMed ID: 34416800
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the role of serum DcR3 levels in the early clinical prognosis of patients with Crimean-Congo hemorrhagic fever.
Kerget F; Kerget B; Laloglu E
Clin Biochem; 2023 Aug; 118():110574. PubMed ID: 37100109
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey.
Hatipoglu CA; Bulut C; Yetkin MA; Ertem GT; Erdinc FS; Kilic EK; Sari T; Kinikli S; Oral B; Demiroz AP
Scand J Infect Dis; 2010 Jul; 42(6-7):516-21. PubMed ID: 20166862
[TBL] [Abstract][Full Text] [Related]
10. Mean platelet volume in the diagnosis and prognosis of Crimean-Congo hemorrhagic fever.
Ekiz F; Gürbüz Y; Basar Ö; Aytekin G; Ekiz Ö; Sentürk ÇŞ; Aktas B; Yılmaz B; Altınbaş A; Çoban Ş; Şencan İ
Clin Appl Thromb Hemost; 2013; 19(4):441-4. PubMed ID: 22431857
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of the different biomarkers to discriminate bleeding in Crimean-Congo Hemorrhagic Fever.
Büyüktuna SA; Doğan HO; Unlusavuran M; Bakir M
Ticks Tick Borne Dis; 2019 Aug; 10(5):997-1002. PubMed ID: 31151923
[TBL] [Abstract][Full Text] [Related]
12. Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?
Duygu F; Kaya T; Baysan P
Vector Borne Zoonotic Dis; 2012 Sep; 12(9):812-6. PubMed ID: 22007611
[TBL] [Abstract][Full Text] [Related]
13. [A Case of Simultaneous Acute Lymphoblastic Leukemia Diagnosis with Crimean-Congo Hemorrhagic Fever].
Çayıröz P; Çayıröz MU; Iltar U; Kurtoğlu E
Mikrobiyol Bul; 2020 Apr; 54(2):326-333. PubMed ID: 32723287
[TBL] [Abstract][Full Text] [Related]
14. Crimean-Congo Hemorrhagic Fever (CCHF) in Afghanistan: A retrospective single center study.
Qaderi S; Mardani M; Shah A; Shah J; Bazgir N; Sayad J; Ghandchi E; Samsami M; Bagherpour JZ
Int J Infect Dis; 2021 Feb; 103():323-328. PubMed ID: 33278621
[TBL] [Abstract][Full Text] [Related]
15. First Crimean-Congo hemorrhagic fever outbreak in India.
Patel AK; Patel KK; Mehta M; Parikh TM; Toshniwal H; Patel K
J Assoc Physicians India; 2011 Sep; 59():585-9. PubMed ID: 22334974
[TBL] [Abstract][Full Text] [Related]
16. Predictive epidemiological, clinical and laboratory parameters in the diagnosis of Crimean-Congo hemorrhagic fever.
Kaygusuz TÖ; Tartar AS; Balin ŞÖ; Akbulut A; Demirdağ K
Biomark Med; 2023 Jun; 17(11):533-540. PubMed ID: 37791843
[No Abstract] [Full Text] [Related]
17. Crimean-Congo Hemorrhagic Fever Case Series: a Chronology of Biochemical and Hematological Parameters.
Amin S; Rahim F; Mahmood A; Gul H; Noor M; Zia A; Ali B; Wahab A; Khan U; Ul Haq F
Cureus; 2022 Sep; 14(9):e29619. PubMed ID: 36321017
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever.
Tasdelen Fisgin N; Tanyel E; Doganci L; Tulek N
Trop Doct; 2009 Jul; 39(3):158-60. PubMed ID: 19535753
[TBL] [Abstract][Full Text] [Related]
19. Crimean-Congo hemorrhagic fever in children.
Tezer H; Sucakli IA; Sayli TR; Celikel E; Yakut I; Kara A; Tunc B; Ergonul O
J Clin Virol; 2010 Jul; 48(3):184-6. PubMed ID: 20444644
[TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality.
Cevik MA; Erbay A; Bodur H; Gülderen E; Baştuğ A; Kubar A; Akinci E
Int J Infect Dis; 2008 Jul; 12(4):374-9. PubMed ID: 18063402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
